Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BWIN
BWIN logo

BWIN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Baldwin Insurance Group, Inc (BWIN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.370
1 Day change
-3.26%
52 Week Range
47.150
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Baldwin Insurance Group, Inc (BWIN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts such as hedge fund buying and analyst upgrades, the lack of strong technical signals, insider selling, and the company's negative net income suggest that it may be better to wait for clearer signs of improvement before investing.

Technical Analysis

The MACD is positive and contracting, indicating mild bullish momentum. RSI is neutral at 54.767, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing indecision in price direction. Key support is at 19.695, and resistance is at 21.903. Overall, the technical indicators are neutral.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
3

Positive Catalysts

  • Hedge funds are significantly increasing their buying activity (+684.07% over the last quarter). Analysts from Raymond James and TD Cowen have upgraded the stock, citing valuation and growth potential. The company has a compelling valuation and synergies from its recent CAC Group merger.

Neutral/Negative Catalysts

  • Insiders are selling heavily (+577.76% over the last month). The stock is down 23% year-to-date due to AI concerns and near-term headwinds on organic revenue growth. No recent news or significant event-driven catalysts. The company is still reporting negative net income (-$25.86M in Q4 2025).

Financial Performance

In Q4 2025, revenue increased by 84.83% YoY to $95.08M, but net income remained negative at -$25.86M, albeit improving by 28.27% YoY. EPS also improved slightly to -0.37 (+12.12% YoY). Gross margin remains at 0%. While revenue growth is strong, the company is still unprofitable.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst ratings are mixed but lean positive. UBS lowered its price target to $40 from $44 while maintaining a Buy rating. Raymond James upgraded the stock to Strong Buy with a price target of $30, citing valuation and growth potential. TD Cowen initiated coverage with a Buy rating and a $37 price target. However, JPMorgan and Raymond James previously lowered their price targets due to AI concerns and growth headwinds.

Wall Street analysts forecast BWIN stock price to rise
6 Analyst Rating
Wall Street analysts forecast BWIN stock price to rise
2 Buy
4 Hold
0 Sell
Moderate Buy
Current: 22.090
sliders
Low
27
Averages
33.67
High
47
Current: 22.090
sliders
Low
27
Averages
33.67
High
47
UBS
Buy
downgrade
$44 -> $40
AI Analysis
2026-03-09
Reason
UBS
Price Target
$44 -> $40
AI Analysis
2026-03-09
downgrade
Buy
Reason
UBS lowered the firm's price target on Baldwin Group to $40 from $44 and keeps a Buy rating on the shares.
Raymond James
Outperform -> Strong Buy
upgrade
$20 -> $30
2026-02-27
Reason
Raymond James
Price Target
$20 -> $30
2026-02-27
upgrade
Outperform -> Strong Buy
Reason
Raymond James upgraded Baldwin Group to Strong Buy from Outperform with a price target of $30, up from $20. The shares have dropped 23% year-to-date due in part to AI concerns and near-term headwinds on organic revenue growth, the analyst tells investors in a research note. The firm cites valuation and Baldwin's 2026 growth profile for the upgrade. Management emphasized that share repurchases are the best use of cash in the near term due to the current valuation, Raymond James points out.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BWIN
Unlock Now

People Also Watch